These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12133406)

  • 41. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus.
    Velickovic M; Delahunt B; Grebe SK
    Cancer Res; 1999 Mar; 59(6):1323-6. PubMed ID: 10096566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
    Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Detection of loss of heterozygosity by microsatellite probe and DNA content analysis].
    Chiba W; Sawai S; Ikeda S; Kinoshita M; Hatama T; Shin S; Fujimoto T; Miyajima S; Wazawa H; Hanawa T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():158-63. PubMed ID: 7611781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects.
    Castagnaro A; Marangio E; Verduri A; Chetta A; D'Ippolito R; Del Donno M; Olivieri D; Di Cola G
    Exp Lung Res; 2007 Aug; 33(6):289-301. PubMed ID: 17694439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.
    Schurr P; Wolter S; Kaifi J; Reichelt U; Kleinhans H; Wachowiak R; Yekebas E; Strate T; Kalinin V; Simon R; Sauter G; Schaefer H; Izbicki J
    Clin Cancer Res; 2006 Sep; 12(17):5151-7. PubMed ID: 16951233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
    Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
    Fujiwara Y; Chi DD; Wang H; Keleman P; Morton DL; Turner R; Hoon DS
    Cancer Res; 1999 Apr; 59(7):1567-71. PubMed ID: 10197630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.
    Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R
    Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables.
    Koo SH; Jeong TE; Kang J; Kwon KC; Park JW; Noh SM
    Cancer Genet Cytogenet; 2004 Aug; 153(1):26-31. PubMed ID: 15325090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
    Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
    Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis.
    Inoue T; Uchino S; Shiraishi N; Adachi Y; Kitano S
    Clin Cancer Res; 1998 Apr; 4(4):973-7. PubMed ID: 9563892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.